Evaluation of Janus Kinase 2 Exon 12 Mutations in Patients With JAK2V617F-negative Polycythemia Vera.

Khosravi, Sahar; Chahardouli, Bahram; Ebrahimi, Pouyan; Babaei, Fatemeh N; Alimoghadam, Kamran; Rostami, Shahrbano

Khosravi, Sahar; Chahardouli, Bahram; Ebrahimi, Pouyan; Babaei, Fatemeh N; Alimoghadam, Kamran; Rostami, Shahrbano.

Afiliação

Khosravi S; Hematology Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Chahardouli B; Hematology Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Ebrahimi P; Student Research Committee, Babol University of Medical Sciences, Babol, Iran.
Babaei FN; Student Research Committee, Babol University of Medical Sciences, Babol, Iran.
Alimoghadam K; Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.
Rostami S; Hematology Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran.

Hematol Oncol Stem Cell Ther ; 17(2): 154-158, 2024 Mar 22.

Article em En | MEDLINE | ID: mdl-38560972

Assuntos

Policitemia Vera; Mielofibrose Primária; Humanos; Policitemia Vera/genética; Janus Quinase 2/genética; Mutação; Mielofibrose Primária/genética; Éxons/genética

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Policitemia Vera / Mielofibrose Primária Limite: Humans Idioma: En Revista: Hematol Oncol Stem Cell Ther Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google